ArticleThe journal of obstetrics and gynaecology research2026
Delivery Outcomes in the First 3 Years Following the Clinical Introduction of the Dinoprostone Vaginal Insert in Japan.
Article in The journal of obstetrics and gynaecology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate utilization patterns, safety, and delivery outcomes associated with the recently introduced dinoprostone vaginal insert in Japan using multicenter real-world data.
methodsThis two-stage nationwide survey targeted training institutions certified by the Japan Society of Obstetrics and Gynecology. An online questionnaire was sent to 690 institutions to identify facilities eligible for secondary data collection. Participating institutions submitted clinical information for up to 25 consecutive cases in which labor was induced with the insert between January and December 2021. Patient characteristics, insert use, delivery outcomes, and adverse events were summarized. In nulliparas, two subgroup comparisons were conducted: (1) those achieving cervical ripening with the insert alone (P) versus those requiring subsequent mechanical ripening (P to M), and (2) those receiving mechanical ripening before the insert (M to P) versus those receiving the insert first (P to M).
resultsOf 973 registered cases from 69 institutions, 947 were eligible for analysis. Nulliparous women accounted for 74.8%. The cesarean section rate was 30.7% overall (36.3% in nulliparas; 14.2% in multiparas). Median time from insert initiation to delivery was 31.6 h. Uterine tachysystole occurred in 18.1% and fetal heart rate abnormalities in 15.8%, but timely management prevented serious outcomes. In subgroup analyses, nulliparas ripened with the insert alone demonstrated shorter induction-to-delivery intervals, lower cesarean and oxytocin-use rates, but more tachysystole. Among cases requiring both methods, the order of ripening techniques did not affect vaginal delivery success.
conclusionThis first multicenter real-world evaluation demonstrates that the insert is effective and generally safe for cervical ripening and labor induction in Japan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.